- Home
- ACIU vs HSHP Comparison
ACIU vs HSHP Comparison
Compare ACIU & HSHP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- HSHP
- Stock Information
- Founded
- ACIU 2003
- HSHP 2021
- Country
- ACIU Switzerland
- HSHP Bermuda
- Employees
- ACIU N/A
- HSHP N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- HSHP
- Sector
- ACIU Health Care
- HSHP
- Exchange
- ACIU Nasdaq
- HSHP Nasdaq
- Market Cap
- ACIU 247.4M
- HSHP 248.0M
- IPO Year
- ACIU 2016
- HSHP 2023
- Fundamental
- Price
- ACIU $1.77
- HSHP $5.36
- Analyst Decision
- ACIU Strong Buy
- HSHP
- Analyst Count
- ACIU 2
- HSHP 0
- Target Price
- ACIU $12.00
- HSHP N/A
- AVG Volume (30 Days)
- ACIU 185.3K
- HSHP 170.0K
- Earning Date
- ACIU 05-12-2025
- HSHP 05-20-2025
- Dividend Yield
- ACIU N/A
- HSHP 8.53%
- EPS Growth
- ACIU N/A
- HSHP 1123.58
- EPS
- ACIU N/A
- HSHP 0.48
- Revenue
- ACIU $30,136,397.00
- HSHP $123,580,000.00
- Revenue This Year
- ACIU N/A
- HSHP $11.04
- Revenue Next Year
- ACIU $680.74
- HSHP $26.01
- P/E Ratio
- ACIU N/A
- HSHP $12.32
- Revenue Growth
- ACIU 84.51
- HSHP 236.40
- 52 Week Low
- ACIU $1.77
- HSHP $4.48
- 52 Week High
- ACIU $4.98
- HSHP $9.76
- Technical
- Relative Strength Index (RSI)
- ACIU 25.49
- HSHP 42.90
- Support Level
- ACIU $1.77
- HSHP $5.40
- Resistance Level
- ACIU $2.05
- HSHP $5.57
- Average True Range (ATR)
- ACIU 0.12
- HSHP 0.16
- MACD
- ACIU -0.02
- HSHP -0.08
- Stochastic Oscillator
- ACIU 0.00
- HSHP 11.25
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About HSHP Himalaya Shipping Ltd.
Himalaya Shipping Ltd is an independent dry bulk company that focuses on owning and operating its Newcastlemax dry bulk carriers.